Hyde Park Capital Advises Infiniti Medical on its Sale to CIMA Animal Health, a Portfolio Company of Incline Equity Partners
SAN FRANCISCO, March 13, 2025 /PRNewswire/ -- Hyde Park Capital announced today that its client, Infiniti Medical LLC (and its subsidiary Orthomed UK Ltd), two globally recognized brands specializing in veterinary interventional radiology, cardiology, soft tissue surgery, and orthopedics, has been acquired by Creative Science, a CIMA Animal Health company, and a leader in veterinary medical solutions. CIMA Animal Health, a portfolio company of Incline Equity Partners, is dedicated to improving the lives of animals and those who care for them. Hyde Park Capital, led by Managing Director Craig Lawson, served as the exclusive financial advisor to Infiniti Medical for this transaction.
This acquisition reinforces Creative Science's dedication to delivering innovative solutions that elevate the quality of care in veterinary medicine. Infiniti Medical remains at the forefront of the global animal health technology industry, supplying veterinarians worldwide with cutting-edge products.
Founded in Silicon Valley, Infiniti Medical has been a trailblazer in developing innovative veterinary technologies, from its revolutionary Vet Stent solutions to advancements in diagnostics, telemedicine, and digital health. Meanwhile, Orthomed has built a strong reputation over the past 15 years for its high-quality orthopedic implants and instruments, consistently raising the standard for surgical precision in veterinary care.
"This acquisition represents an exciting opportunity to expand our impact on veterinary medicine," said Lynn Snodgrass, CEO of CIMA Animal Health. "Infiniti Medical and Orthomed are trailblazers in their respective fields, and by joining forces, we can accelerate innovation and provide even greater value to veterinary professionals worldwide."
Jared Finegold, CEO of Infiniti Medical, expressed enthusiasm for the partnership: "Infiniti Medical was founded on the belief that advanced technology could revolutionize veterinary medicine. By partnering with Creative Science, we will continue to scale our efforts, invest further in veterinary medical device innovations, and accelerate our development of cutting-edge technologies and training solutions for veterinarians across the globe."
Craig Lawson, Managing Director at Hyde Park Capital, also highlighted the significance of the transaction, "Infiniti Medical and Orthomed have built an outstanding legacy of innovation in veterinary medicine. This partnership with Creative Science is a natural fit and positions these brands for even greater success. We are proud to have advised Infiniti Medical on this strategic move and look forward to seeing the impact this collaboration will have on the future of veterinary care."
About Infiniti Medical
Infiniti Medical is a global leader in veterinary medical technology, specializing in interventional radiology, cardiology, soft tissue surgery, and orthopedics. Founded in Silicon Valley, Infiniti Medical has been at the forefront of developing groundbreaking veterinary devices and solutions, including its pioneering Vet Stent technology. With a strong commitment to innovation, education, and advancing animal healthcare, Infiniti Medical provides cutting-edge tools and training to veterinarians worldwide. Through its subsidiary, Orthomed UK Ltd, the company also offers industry-leading orthopedic implants and instruments, setting new standards for surgical excellence. For more information, visit www.infinitimedical.com.
About Creative Science
Creative Science is a leading provider of innovative animal health solutions, formed from the merging of several veterinary-trusted companies, including Arenus Animal Health, Kinetic Vet, Banixx, Equine Medical & Surgical Associates, Breeder's Choice, and Exodus Breeders. With a strong commitment to science and service, Creative Science's mission is to bridge the critical gaps in pet, livestock, and equine care, ensuring that veterinarians, owners, and producers have access to essential tools, advancing animal healthcare and supporting animals' overall well-being. For more information about Creative Science, please visit www.creative.science.
About Hyde Park Capital
Hyde Park Capital is an institutionally focused boutique investment banking firm specializing in mergers and acquisitions and focusing on serving the corporate finance needs of successful founder and family-owned companies. Hyde Park's principals have extensive investment banking experience managing merger and acquisition engagements, including executing sell-side and buy-side sale of company assignments, recapitalizations, financial advisory services, fairness opinions, and raising growth capital and acquisition financing for companies, including equity, mezzanine, and senior debt. Hyde Park Capital has extensive experience across numerous industry sectors, including industrial, technology, consumer, healthcare, business, and financial services. Hyde Park Capital is headquartered in Tampa, Florida, and is a member of FINRA and SIPC. Hyde Park Capital is also a member of the Geneva Capital Group (GCG) International M&A Alliance (see www.gcg.com). For additional information, please visit www.hydeparkcapital.com.
Media Contacts:
Craig Lawson
Hyde Park Capital
(415) 515-6315
SOURCE Hyde Park Capital
Share this article